Deere & Company’s Fortress Biotech FBIO Stock Holding History

Deere & Company’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,625	Closed	-$209K	–	1023
2015 Q1	$209K	Buy	+3,625	New	+$151K	0.01%	876

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

Deere & Company's FBIO Position: Q2 2015 in Review

Deere & Company sold out of Fortress Biotech (FBIO) in Q2 2015, closing a stake of 3,625 shares — an estimated $209K sold.

Deere & Company first reported a position in FBIO in Q1 2015 and held it in 1 quarter. The position peaked at $209K in Q1 2015. 41 funds tracked by Wall St. Rank hold FBIO as of Q2 2015.

Deere & Company reported no remaining Fortress Biotech position as of Q2 2015 after selling out during the quarter.
Deere & Company sold 3,625 Fortress Biotech shares in Q2 2015, an estimated $209K.
Deere & Company first reported a position in Fortress Biotech in Q1 2015 and held it in 1 quarter.
Deere & Company's Fortress Biotech position peaked at $209K in Q1 2015.
41 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2015.

Based on Deere & Company's 13F filing for Q2 2015, filed 13 Aug 2015.